BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 14692784)

  • 1. Determination of the active site protonation state of beta-secretase from molecular dynamics simulation and docking experiment: implications for structure-based inhibitor design.
    Park H; Lee S
    J Am Chem Soc; 2003 Dec; 125(52):16416-22. PubMed ID: 14692784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virtual screening for beta-secretase (BACE1) inhibitors reveals the importance of protonation states at Asp32 and Asp228.
    Polgár T; Keserü GM
    J Med Chem; 2005 Jun; 48(11):3749-55. PubMed ID: 15916426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional plasticity in the substrate binding site of beta-secretase.
    Gorfe AA; Caflisch A
    Structure; 2005 Oct; 13(10):1487-98. PubMed ID: 16216580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apo and inhibitor complex structures of BACE (beta-secretase).
    Patel S; Vuillard L; Cleasby A; Murray CW; Yon J
    J Mol Biol; 2004 Oct; 343(2):407-16. PubMed ID: 15451669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a small molecule nonpeptide active site beta-secretase inhibitor that displays a nontraditional binding mode for aspartyl proteases.
    Coburn CA; Stachel SJ; Li YM; Rush DM; Steele TG; Chen-Dodson E; Holloway MK; Xu M; Huang Q; Lai MT; DiMuzio J; Crouthamel MC; Shi XP; Sardana V; Chen Z; Munshi S; Kuo L; Makara GM; Annis DA; Tadikonda PK; Nash HM; Vacca JP; Wang T
    J Med Chem; 2004 Dec; 47(25):6117-9. PubMed ID: 15566281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aminoethylenes: a tetrahedral intermediate isostere yielding potent inhibitors of the aspartyl protease BACE-1.
    Yang W; Lu W; Lu Y; Zhong M; Sun J; Thomas AE; Wilkinson JM; Fucini RV; Lam M; Randal M; Shi XP; Jacobs JW; McDowell RS; Gordon EM; Ballinger MD
    J Med Chem; 2006 Feb; 49(3):839-42. PubMed ID: 16451048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling the protonation states of β-secretase binding pocket by molecular dynamics simulations and docking studies.
    Sabbah DA; Zhong HA
    J Mol Graph Model; 2016 Jul; 68():206-215. PubMed ID: 27474865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A method for induced-fit docking, scoring, and ranking of flexible ligands. Application to peptidic and pseudopeptidic beta-secretase (BACE 1) inhibitors.
    Moitessier N; Therrien E; Hanessian S
    J Med Chem; 2006 Oct; 49(20):5885-94. PubMed ID: 17004704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Why does beta-secretase zymogen possess catalytic activity? Molecular modeling and molecular dynamics simulation studies.
    Zuo Z; Gang C; Zou H; Mok PC; Zhu W; Chen K; Jiang H
    Comput Biol Chem; 2007 Jun; 31(3):186-95. PubMed ID: 17500040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular docking and 3D-QSAR studies on the binding mechanism of statine-based peptidomimetics with beta-secretase.
    Zuo Z; Luo X; Zhu W; Shen J; Shen X; Jiang H; Chen K
    Bioorg Med Chem; 2005 Mar; 13(6):2121-31. PubMed ID: 15727865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computational insights into the protonation states of catalytic dyad in BACE1-acyl guanidine based inhibitor complex.
    Kocak A; Erol I; Yildiz M; Can H
    J Mol Graph Model; 2016 Nov; 70():226-235. PubMed ID: 27770745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-based design of cycloamide-urethane-derived novel inhibitors of human brain memapsin 2 (beta-secretase).
    Ghosh AK; Devasamudram T; Hong L; DeZutter C; Xu X; Weerasena V; Koelsch G; Bilcer G; Tang J
    Bioorg Med Chem Lett; 2005 Jan; 15(1):15-20. PubMed ID: 15582402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of cyclic acylguanidines as highly potent and selective beta-site amyloid cleaving enzyme (BACE) inhibitors: Part I--inhibitor design and validation.
    Zhu Z; Sun ZY; Ye Y; Voigt J; Strickland C; Smith EM; Cumming J; Wang L; Wong J; Wang YS; Wyss DF; Chen X; Kuvelkar R; Kennedy ME; Favreau L; Parker E; McKittrick BA; Stamford A; Czarniecki M; Greenlee W; Hunter JC
    J Med Chem; 2010 Feb; 53(3):951-65. PubMed ID: 20043696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naphthyl and coumarinyl biarylpiperazine derivatives as highly potent human beta-secretase inhibitors. Design, synthesis, and enzymatic BACE-1 and cell assays.
    Garino C; Tomita T; Pietrancosta N; Laras Y; Rosas R; Herbette G; Maigret B; Quéléver G; Iwatsubo T; Kraus JL
    J Med Chem; 2006 Jul; 49(14):4275-85. PubMed ID: 16821787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conserved residues within the putative active site of gamma-secretase differentially influence enzyme activity and inhibitor binding.
    Wrigley JD; Nunn EJ; Nyabi O; Clarke EE; Hunt P; Nadin A; De Strooper B; Shearman MS; Beher D
    J Neurochem; 2004 Sep; 90(6):1312-20. PubMed ID: 15341515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformational flexibility of beta-secretase: molecular dynamics simulation and essential dynamics analysis.
    Xiong B; Huang XQ; Shen LL; Shen JH; Luo XM; Shen X; Jiang HL; Chen KX
    Acta Pharmacol Sin; 2004 Jun; 25(6):705-13. PubMed ID: 15169620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling the binding affinities of beta-secretase inhibitors: application to subsite specificity.
    Rajamani R; Reynolds CH
    Bioorg Med Chem Lett; 2004 Oct; 14(19):4843-6. PubMed ID: 15341936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and synthesis of hydroxyethylene-based peptidomimetic inhibitors of human beta-secretase.
    Hom RK; Gailunas AF; Mamo S; Fang LY; Tung JS; Walker DE; Davis D; Thorsett ED; Jewett NE; Moon JB; John V
    J Med Chem; 2004 Jan; 47(1):158-64. PubMed ID: 14695829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-based design of potent and selective cell-permeable inhibitors of human beta-secretase (BACE-1).
    Stachel SJ; Coburn CA; Steele TG; Jones KG; Loutzenhiser EF; Gregro AR; Rajapakse HA; Lai MT; Crouthamel MC; Xu M; Tugusheva K; Lineberger JE; Pietrak BL; Espeseth AS; Shi XP; Chen-Dodson E; Holloway MK; Munshi S; Simon AJ; Kuo L; Vacca JP
    J Med Chem; 2004 Dec; 47(26):6447-50. PubMed ID: 15588077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, and X-ray structure of potent memapsin 2 (beta-secretase) inhibitors with isophthalamide derivatives as the P2-P3-ligands.
    Ghosh AK; Kumaragurubaran N; Hong L; Kulkarni SS; Xu X; Chang W; Weerasena V; Turner R; Koelsch G; Bilcer G; Tang J
    J Med Chem; 2007 May; 50(10):2399-407. PubMed ID: 17432843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.